Fennec Pharmaceuticals (FENC) Interest & Investment Income (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Interest & Investment Income of $228000.0 for Q4 2025, up 50.0% on a QoQ basis from $152000.0 in Q3 2025, and down 42.86% year-over-year from $399000.0 in Q4 2024.
Fennec Pharmaceuticals (FENC) Interest & Investment Income (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Interest & Investment Income history runs 16 years deep, the most recent figure standing at $228000.0 for Q4 2025.
- Quarterly Interest & Investment Income fell 42.86% year-over-year to $228000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $787000.0 (down 53.21% YoY) and the FY2025 annual result came in at $787000.0, down 53.21% from the prior year.
- Interest & Investment Income was $228000.0 for Q4 2025 at Fennec Pharmaceuticals, up from $152000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $570000.0 in Q2 2024 and bottomed at $9000.0 in Q1 2022.
- A 5-year average of $157950.0 and a median of $115000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 1177.78% — and 2025, when it tumbled 70.54%.
- Fennec Pharmaceuticals' Interest & Investment Income stood at $13000.0 in 2021, then surged by 1076.92% to $153000.0 in 2022, then dropped by 24.84% to $115000.0 in 2023, then jumped by 246.96% to $399000.0 in 2024, then slumped by 42.86% to $228000.0 in 2025.
- Business Quant data shows FENC's Interest & Investment Income at $228000.0 in Q4 2025, $152000.0 in Q3 2025, and $171000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | 228,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 228,000.00 |
| Sep 30, 2025 | 152,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 236,000.00 |
| Dec 31, 2024 | 399,000.00 |
| Sep 30, 2024 | 516,000.00 |
| Jun 30, 2024 | 570,000.00 |
| Mar 31, 2024 | 197,000.00 |
| Dec 31, 2023 | 115,000.00 |
| Sep 30, 2023 | 102,000.00 |
| Jun 30, 2023 | 115,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | 153,000.00 |
| Sep 30, 2022 | 24,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 16,000.00 |